Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
Study Details
Study Description
Brief Summary
The goal of this interventional clinical trial is to assess opioid consumption 24-48 hrs post anesthesia block among patients undergoing total knee arthroplasty. The main question it aims to answer is:
- Is there a difference in opioid consumption 24-48 hours post block administration among patients that receive an adductor canal catheter (ACC) versus adductor canal block (ACB)?
Participants will be:
-
Randomized to receive an adductor canal catheter (ACC) or a sham adductor canal catheter.
-
Asked to use the Diagnotes application to communicate with the pain doctor while the catheter is in place.
-
Follow up for up to 6 months post-operation. Researchers will compare the interventional group (ACC) to the control group (sham ACC + ACB) to see if there is difference in opioid consumption and chronic pain at 6 months post-operation.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The purpose of this study is to see if adding a continuous ACB catheter will extend analgesia beyond the 24-48 hour period. This interventional clinical trial will assess opioid consumption in patients undergoing total knee arthroplasty 24 to 48 hours after anesthesia block. Rebound pain is a well-known phenomenon in which patients experience severe pain immediately after the nerve block is removed. It is also known that by extending the duration of analgesia, you can reduce or prevent rebound pain. Motor sparing compartment blocks have transformed patients' ability to participate in rehabilitation earlier than ever before, even ambulating on POD 0. Thus, by extending analgesia and encouraging early ambulation, adductor canal catheters are likely to not only reduce opioid consumption but also allow for earlier discharge. The two "hot" themes in recent total knee replacement analgesia pathways are not only providing an effective Enhanced recovery after surgery (ERAD) protocol, but also combating the opioid epidemic through regional anesthesia and non-opioid multimodal pathways. This study will assist in determining which modality is superior (single shot blocks with additive versus catheter) and will introduce a novel method of following patients at home via a transitional pain service (telemedicine). This research will further investigate chronic pain 6 months after surgery.
Patients in the intervention group will have a catheter that continuously infuses numbing medication into their operative leg for 50 hours (up to POD 3). It is hypothesized that the patient will have better pain control, mobility, and less rebound pain, which is common following POD 1. By infusing the catheter with a disposable single use ambIT system (Summit Medical Products), all patients enrolled in the intervention group (ACC) will have the same amount running continuously, allowing the patient to be discharged with the catheter in place before the 50-hour infusion is completed. Prior to discharge, patients will be instructed on how to remove the catheter and will be able to download the Smartphone app "Diagnotes" at the hospital. While the catheter is in place, the Diagnotes app (a HIPPA-compliant text messaging service) will be the patient's primary means of communication with the pain doctor at home.
Patients in the control group will have a sham (fake) catheter attached to their operative leg for 50 hours. Patients will also be instructed on how to remove the catheter prior to discharge and will be able to download the Smartphone app "Diagnotes" in the hospital. While the catheter is in place, the Diagnotes app (a HIPPA-compliant text messaging service) will be the patient's primary means of communication with the pain doctor at home.
Researchers will contact both groups for follow-ups for up to 6 months.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Adductor Canal Catheter (ACC) - Interventional Patients will received the an adductor canal catheter that continuously infuses numbing medication to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place. |
Device: ambIT pump with catheter
0.2% ropivacaine will be infused through a catheter pump at a rate of 10 ml/hr, 600 ml reservoir.
|
| Sham Comparator: Adductor Canal Block (ACB) - Control Patients will received the a sham adductor canal catheter that is attached to their operative leg for 50 hours post-surgery. Patients will also communicate with their pain doctor via the Diagnotes application while the catheter is in place. |
Device: ambIT pump with sham catheter
sham catheter with no infusion
|
Outcome Measures
Primary Outcome Measures
- Opioid consumption at 24-48 hours [from 24 hours to 48 hours]
The cumulative opioid consumption 24-48 hours post block administration. Measured in morphine milligram equivalents per day. Although collected over a period of time, the total amount will be summed and the average will be reported.
Secondary Outcome Measures
- Opioid consumption at 72 hours, 96 hours, and 1 week [72 hours to 1 week]
The cumulative opioid consumption 72hours, 96 hours, and 1 week post block administration. Measured in morphine milligram equivalents per day. Although collected over a period of time, the total amount will be summed and the average will be reported.
- Numerical Pain Rating Score [Day of surgery to POD 60]
Patients are asked to give a number between 0 and 10 that best fits their pain intensity. The scale is 0 = 'no pain at all' whereas 10 = 'the worst pain ever possible'. Measured at multiple time points: DOS, post-operative day (POD) 1, POD 2, POD 3, POD 4, POD 7, & POD 60
- Physical Therapy Milestones [post operative day (POD) 1 up to POD 4]
Collected from the physical therapy notes. This outcome will assess for time to ambulation (measured in distance traveled, stairs, time of ambulating > 30 meters, and reaching discharge criteria).
- Patient Satisfaction with Pain Control [post operative day (POD) 1, 2, 4 & 60]
Patients are asked to report on their satisfaction with pain control on a scale of 0 to 10, with 0 = extremely dissatisfied and 10 = extremely satisfied.
- Hospital Length of Stay [up to 7 days after the day of surgery]
From when the patient is in the PACU to when the patient has been discharged from the hospital. PACU time = "PACU Transfer In" and Discharge time = "Discharge"
- Opioid Related Symptom Distress Scale (ORSDS) [after the surgery end time, on post operative day (POD) 1, 4, and 60]
The Opioid-Related Symptom Distress Scale (ORSDS) is a 4-point scale that evaluates 3 symptom distress dimensions (frequency, severity, bothersomeness) for 12 symptoms. The symptom-specific ORSDS is the average of the 3 symptom distress dimensions. The composite ORSDS is the average of 12 symptom-specific scores.
- Number of participants who experienced Buckling/Falls/Quadricep during physical therapy [On post operative day (POD) 1, 2, 3, 4]
Whether a participant experiences buckling, falls, or quadricep weakness during physical therapy, precluding ambulation.
- Incidents of participants experiencing a blood loss during surgical procedure [During surgery]
Whether the participant experienced any blood loss during their surgical procedure. Measured in binary responses (yes/no).
- Block resolution [Up to post operative day 3]
The patient will be asked in the morning of POD 1 when they feel the block has worn off, and in the evening of POD 3 after the catheter has been removed.
- Distance of ambulation [post operative day (POD) 0,1,2,3,4]
The total distance of ambulation during physical therapy while the patient is inpatient, collected from the physical therapy notes.
- Catheter related complications [up to post operative day 4]
Patient will be asked if they have experience any of the following with regards to the catheter: delayed weakness, unintentional dislodgment, leakage, catheter infection, dysesthesias, falls, LAST
- Incidences of participants readmitted for pain control [3 month after surgery]
Whether the patient was readmitted to a hospital for additional pain control.
- Block complications [up to post operative day 4]
Patients will report if they experience any block complications including, neuropraxia (saphenous), transient palsies: peroneal, tibial nerve.
- Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.) [before surgery and up to post operative day 60]
The survey asks for patients' view about their knee, such as how they feel about their knee and how well they are able to do usual activities. Choices on each question are: none, mild, moderate, severe, extreme
- Orthopedic Outcome Flexion/Knee Society Score [6 weeks]
Patient will be asked about their range of motion (flexion ROM and Extension ROM). Data collected from surgeon's note
- SF-36 questionnaire [up to post operative day 60]
The SF-36 measures includes the following: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). Measured on a scale of 1 to 3, with 1 = "yes limited a lot", 2 = "yes limited a little", 3 = "no not limited at all". The total score for each participant is calculated and then all the scores are average across all participants.
- Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) [at 3 months & 6 months]
The Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS) comprises of a 7-item pain scale, including the sensory descriptors and items for sensory examination. Out of the seven items in the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS), five are symptom related and two are examination items. If patient reports surgery-related pain greater than 3 on the NRS at the 3 months and 6 months postoperative visit, patient will complete this questionnaire.
- Current opioid misuse measure (COMM) [at 3 months & 6 months]
The Current Opioid Misuse Measure (COMM) is a commonly used self-report instrument to identify and monitor aberrant opioid-related behavior in chronic pain patients on opioid therapy. At the 3 months and 6 months postoperative visit, if patients are still being prescribed opioids, patient will be asked to fill out the questionnaire Choices on the questionnaire are: never, seldom, sometimes, often, very often
- Incidence of patient contact via text messaging/video calls [up to post operative day 4]
Research staff will mark if patients contacted the pain doctor via the Diagnotes application.
- Number of unused opioids [up to post operative day 7]
Patients will be asked at 1 week post-operation, about their pain medication usage (how many pills of your opioid medication do you have left?)
- Pain catastrophizing scale (PCS) [before the surgery and up to post operative day 60]
The Pain Catastrophizing Scale (PCS) assesses the extent of catastrophic thinking due to low back pain according to 3 components: rumination, magnification, and helplessness. It is a 13-item scale, with a total range of 0 to 52. Higher scores are associated with higher amounts of pain catastrophizing.
- Pain Disability Index (PDI) [3 months & 6 months]
The Pain Disability Index (PDI) is a widely-used instrument to measure pain-related disability. Scoring: Scores are assigned based on an 11-point scale ranging from 0 (no disability) to 10 (total disability). Scores range from 0 to 70. The higher the index the greater the person's disability due to pain.
- Blinding Assessment [up to post operative day 2]
Patient and research staff will report which group they believe the patient was randomized to.
- Incidents of participants experiencing block complications [up to post operative day 4]
Data on whether patient experienced quadriceps weakness and foot drop during physical therapy. Collected from physical therapy notes.
- Non Opioid Pain medications consumption [up to post operative day 60]
Research staff will document any non-opioid pain medications (lyrica, robaxin, tyelnol, etc) taken by each participant. Medications may be given at the discretion of the APS service.
- Intravenous patient control analgesia (IV PCA) usage [up to post operative day 7]
Research staff will document if patient received IV PCA during their stay at the hospital. Measured in morphine equivalent. Discharge times can vary from participant to participant (from POD 0 up until POD 2)
- Length of induction [During the surgical procedure]
The time it takes for the patient to be induced. Measured from induction start to induction end. Times for each participants will be calculated (in minutes) and then average across all participants.
- Length of tourniquet use [During the surgical procedure]
The total time to use a tourniquet. Measured from tourniquet inflated time tourniquet deflated time. Times for each participants will be calculated (in minutes) and then average across all participants.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients with osteoarthritis scheduled for a primary total knee arthroplasty with a participating surgeon
-
Age 18 to 75 years
-
Planned use of regional anesthesia
-
Ability to follow study protocol
-
English speaking (secondary outcomes include questionnaires validated in English only)
-
Patients of participating surgeons: Drs. Mayman, Jerabek, Westrich, Su, Della Valle, Alexiades
-
Lives within one hour of the hospital
-
Has a smartphone
Exclusion Criteria:
-
Hepatic or renal insufficiency
-
Younger than 18 years old and older than 65
-
Patients undergoing general anesthesia
-
Allergy or intolerance to one of the study medications
-
BMI > 40
-
Diabetes
-
ASA of III,IV
-
Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
-
PCS > 30
-
Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of >5mg/day for one month)
-
Patients with severe valgus deformity or flexion contracture
-
Patients unable to follow home catheter instructions and unwilling to go home with an infusing catheter
-
Patients who have no home caregivers in the event if a catheter is to be sent home with the patient
-
Patients with planned stay at rehab facility
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Hospital for Special Surgery | New York | New York | United States | 10021 |
Sponsors and Collaborators
- Hospital for Special Surgery, New York
Investigators
- Principal Investigator: Stavros Memtsoudis, MD/PhD, Hospital for Special Surgery, New York
- Study Director: Justas Lauzadis, PhD, Hospital for Special Surgery, New York
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2017-1858 pt 2